Compare ALDX & YRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALDX | YRD |
|---|---|---|
| Founded | 2004 | 2012 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.7M | 321.4M |
| IPO Year | 2014 | 2015 |
| Metric | ALDX | YRD |
|---|---|---|
| Price | $1.43 | $3.66 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.50 | N/A |
| AVG Volume (30 Days) | ★ 3.4M | 35.1K |
| Earning Date | 02-27-2026 | 03-19-2026 |
| Dividend Yield | N/A | ★ 11.96% |
| EPS Growth | ★ 40.43 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $123.43 | N/A |
| P/E Ratio | ★ N/A | $1.86 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.07 | $3.51 |
| 52 Week High | $6.87 | $7.68 |
| Indicator | ALDX | YRD |
|---|---|---|
| Relative Strength Index (RSI) | 20.13 | 45.26 |
| Support Level | N/A | $3.58 |
| Resistance Level | $5.75 | $3.98 |
| Average True Range (ATR) | 0.45 | 0.14 |
| MACD | -0.40 | -0.01 |
| Stochastic Oscillator | 7.17 | 31.91 |
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
Yiren Digital Ltd is an AI-powered platform providing a comprehensive suite of financial and lifestyle services in China. Its mission is to elevate customers' financial well-being and enhance their quality of life by delivering digital financial services, tailor-made insurance solutions, and premium lifestyle services. The company supports clients at various growth stages, addressing financing needs arising from consumption and production activities, while aiming to augment the overall well-being and security of individuals, families, and businesses.